1887

Chapter 41 : Biodiversity Prospecting: The INBio Experience

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Biodiversity Prospecting: The INBio Experience, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817770/9781555812676_Chap41-1.gif /docserver/preview/fulltext/10.1128/9781555817770/9781555812676_Chap41-2.gif

Abstract:

Bioprospecting is defined as the systematic search for genes, compounds, designs, and organisms that might have a potential economic use and might lead to a product development. In 1991, Costa Rica's National Institute of Biodiversity (INBio) set a landmark when it signed the first commercial bioprospecting research collaborative agreement (RCA) between a pharmaceutical industry and a biodiversity-rich country organization: Merck & Co. and INBio. More recently, the Diversa-INBio RCA was highlighted during the meeting of the Conference of Parties (COP6) in 2002 in The Hague as a “well-known example of an access and benefit-sharing” agreement (CBD, 2002). To date, INBio has signed more than 20 agreements with industry that represent $0.5 million (U.S.) per year for bioprospecting activities and $0.5 million per year for capacity building, technology transfer, and empowerment. INBio's portfolio of research collaborative agreements includes some in the biotechnological area, which involve microorganisms. By 1995 INBio set up a small microbiology laboratory for in-house antibiotic testing and began the long-lasting partnership with Diversa. INBio will continue to promote the development of biotechnological activities, with emphasis on microbial prospecting, isolation, and identification of genes with potential application in the industry and agriculture.

Citation: Tamayo G, Guevara L, Gámez R. 2004. Biodiversity Prospecting: The INBio Experience, p 445-449. In Bull A (ed), Microbial Diversity and Bioprospecting. ASM Press, Washington, DC. doi: 10.1128/9781555817770.ch41

Key Concept Ranking

Caenorhabditis elegans
0.55597705
HIV Integrase
0.55597705
0.55597705
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817770.chap41
1. Bills, G. F.,, and J. D. Polishook. 1994a. Abundance and diversity of micofungi in leaf litter of a lowland rain forest in Costa Rica. Mycologia 86:187198.
2. Bills, G. F.,, and J. D. Polishook. 1994b. Microfungi from decaying leaves of Heliconia mariae. Brenesia 41/42:2743.
3. CBD (Conventionon National Biological Diversity). 2002. First-ever global guidelines adopted on genetic resources Biodiversity conference also acts on forests and invasive species. Press Release. In media only. The Hague, The Netherlands.
4. Finlay, B. J.,, and K. J. Clarke. 1999. Ubiquitous dispersal of microbial species. Nature 400:828.
5. Gámez, R. 2000. Perspectivas del Desarrollo Científico Costarricense: La Vision Desde una Institución Privada, Vol. III. p. 115130. Academia Nacional de Ciencias, San José, Costa Rica.
6. Guevara, A. L. 2002. Los Aportes de La Bioprospección realizada por el INBio. Rev. Ambientico 100:7.
7. Liu, W.,, T. L. Marsh,, H. Cheng,, and L. J. Forney. 1997. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl. Environ. Microbiol 63:45164522.
8. Matamoros, A.,, and R. Garcia (éd.). 2000. Institutional Sustain-ability Strategy. Internal Documents Series no. 1. Editorial IN-Bio, Instituto Nacional de Biodiversidad, Heredia, Costa Rica.
9. Mateo, N.,, W. Nader,, and G. Tamayo,. 2001. Bioprospecting, p. 471478. In S. A. Levin (ed.), Encyclopedia of Biodiversity, vol. 1. Academic Press, New York, N.Y.
10. Moran, K.,, S. King,, and C. Carlson. 2001. Biodiversity prospecting: lessons and prospects. Annu. Rev. Anthropol. 30:505526.
11. Obando, V., 2002. Biodiversidad en Costa Rica: Estado del Conocimiento y Gestión, D. Avila, (ed.). Editorial INBio, Heredia, Costa Rica.
12. O'Neill, M. J.,, and J. A. Lewis,. 1993. The renaissance of plant research in the pharmaceutical industry, p. 4878. In D. Kinghorn, and M. Balandrin (ed.), Human Medicinal Agents from Plants. American Chemical Society, Washington, D.C.
13. Reid, W., et al. 1994. Prospección de la Biodiversidad: El uso de los Recursos Genéticos para el Desarrollo Sostenible. Traducción Centro Universitario de Traducción (CUTRA). Instituto Nacional de Biodiversidad, San José, Costa Rica.
14. Sittenfeld, A.,, and R. Villers,. 1994. Costa Rica's INBio: Collaborative biodiversity research agreements with the pharmaceutical industry. Case study 2, p. 500504. In G. K. Meffe, and C. R. Carrol (ed.), Principles of Conservation Biology. Sinauer Associates, Sunderland, Mass.
15. Sittenfeld, A., et al. 1999. Costa Rican International Cooperative Biodiversity Group: using insects and other arthropods in biodiversity prospecting. Pharm. Biol. 37(Suppl.):l14.
16. Staley, J., 1998. Economic value of microbial diversity. In O. Kirsop, and V. Perez (ed.), Workshop on The Economic Value of Microbial Genetic Resources. Eighth International Symposium on Microbial Ecology. WFCC (World Federation for Culture Collections), Halifax, Canada.
17. Tamayo, G.,, W. F. Nader,, and A. Sittenfeld,. 1997. Biodiversity for bioindustries, p. 255280. In J. A. Callow,, B. V. Ford-Lloyd,, and H. J. Newbury (ed.), Biotechnology and Plant Genetic Resources. CAB International, Wallingford, United Kingdom.
18. ten Kate, K.,, and S. Laird. 1999. The Commercial Use of Biodiversity: Access to Genetic Resources and Benefit-Sharing. European Communities, Brussels.
19. Watkins, K. 2002. Fighting the clock: pharmaceutical and biotechnology companies seek ways to reduce the time required tó discover and development medicines. Chem. Eng. News Jan., p. 34.

Tables

Generic image for table
Table 1

Most significant research collaborative agreements with industry and academia, 1991-2002

Citation: Tamayo G, Guevara L, Gámez R. 2004. Biodiversity Prospecting: The INBio Experience, p 445-449. In Bull A (ed), Microbial Diversity and Bioprospecting. ASM Press, Washington, DC. doi: 10.1128/9781555817770.ch41
Generic image for table
Table 2

Monetary and nonmonetary benefits of bioprospecting

Citation: Tamayo G, Guevara L, Gámez R. 2004. Biodiversity Prospecting: The INBio Experience, p 445-449. In Bull A (ed), Microbial Diversity and Bioprospecting. ASM Press, Washington, DC. doi: 10.1128/9781555817770.ch41
Generic image for table
Table 3

Outputs generated since 1992 as a result of RCA with INBio

Citation: Tamayo G, Guevara L, Gámez R. 2004. Biodiversity Prospecting: The INBio Experience, p 445-449. In Bull A (ed), Microbial Diversity and Bioprospecting. ASM Press, Washington, DC. doi: 10.1128/9781555817770.ch41

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error